Your browser doesn't support javascript.
loading
Prediction of anticancer drug sensitivity using an interpretable model guided by deep learning.
Pang, Weixiong; Chen, Ming; Qin, Yufang.
Afiliação
  • Pang W; College of Information Technology, Shanghai Ocean University, Hucheng Ring Road, Shanghai, China.
  • Chen M; Key Laboratory of Fisheries Information Ministry of Agriculture, Shanghai, China.
  • Qin Y; College of Information Technology, Shanghai Ocean University, Hucheng Ring Road, Shanghai, China.
BMC Bioinformatics ; 25(1): 182, 2024 May 09.
Article em En | MEDLINE | ID: mdl-38724920
ABSTRACT

BACKGROUND:

The prediction of drug sensitivity plays a crucial role in improving the therapeutic effect of drugs. However, testing the effectiveness of drugs is challenging due to the complex mechanism of drug reactions and the lack of interpretability in most machine learning and deep learning methods. Therefore, it is imperative to establish an interpretable model that receives various cell line and drug feature data to learn drug response mechanisms and achieve stable predictions between available datasets.

RESULTS:

This study proposes a new and interpretable deep learning model, DrugGene, which integrates gene expression, gene mutation, gene copy number variation of cancer cells, and chemical characteristics of anticancer drugs to predict their sensitivity. This model comprises two different branches of neural networks, where the first involves a hierarchical structure of biological subsystems that uses the biological processes of human cells to form a visual neural network (VNN) and an interpretable deep neural network for human cancer cells. DrugGene receives genotype input from the cell line and detects changes in the subsystem states. We also employ a traditional artificial neural network (ANN) to capture the chemical structural features of drugs. DrugGene generates final drug response predictions by combining VNN and ANN and integrating their outputs into a fully connected layer. The experimental results using drug sensitivity data extracted from the Cancer Drug Sensitivity Genome Database and the Cancer Treatment Response Portal v2 reveal that the proposed model is better than existing prediction methods. Therefore, our model achieves higher accuracy, learns the reaction mechanisms between anticancer drugs and cell lines from various features, and interprets the model's predicted results.

CONCLUSIONS:

Our method utilizes biological pathways to construct neural networks, which can use genotypes to monitor changes in the state of network subsystems, thereby interpreting the prediction results in the model and achieving satisfactory prediction accuracy. This will help explore new directions in cancer treatment. More available code resources can be downloaded for free from GitHub ( https//github.com/pangweixiong/DrugGene ).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Redes Neurais de Computação / Aprendizado Profundo / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Redes Neurais de Computação / Aprendizado Profundo / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article